

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | folic acid-containing compound biosynthetic process (GO:0009396) | 8.07552750 |
| 2 | purine nucleotide salvage (GO:0032261) | 6.99158930 |
| 3 | homocysteine metabolic process (GO:0050667) | 6.21429782 |
| 4 | regulation of plasminogen activation (GO:0010755) | 6.19716464 |
| 5 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 6.16828198 |
| 6 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 6.16828198 |
| 7 | pteridine-containing compound biosynthetic process (GO:0042559) | 5.48714613 |
| 8 | regulation of gonadotropin secretion (GO:0032276) | 5.46928461 |
| 9 | protein-cofactor linkage (GO:0018065) | 5.35937967 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 5.32286377 |
| 11 | mitochondrial RNA metabolic process (GO:0000959) | 5.06487299 |
| 12 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 4.80802257 |
| 13 | adenosine metabolic process (GO:0046085) | 4.80754926 |
| 14 | platelet dense granule organization (GO:0060155) | 4.60173911 |
| 15 | IMP biosynthetic process (GO:0006188) | 4.59746364 |
| 16 | GMP metabolic process (GO:0046037) | 4.52523465 |
| 17 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.37762887 |
| 18 | NADH dehydrogenase complex assembly (GO:0010257) | 4.37762887 |
| 19 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.37762887 |
| 20 | negative regulation of DNA biosynthetic process (GO:2000279) | 4.30207696 |
| 21 | alternative mRNA splicing, via spliceosome (GO:0000380) | 4.26007477 |
| 22 | cysteine metabolic process (GO:0006534) | 4.20452180 |
| 23 | pseudouridine synthesis (GO:0001522) | 4.17208356 |
| 24 | metallo-sulfur cluster assembly (GO:0031163) | 4.10126534 |
| 25 | iron-sulfur cluster assembly (GO:0016226) | 4.10126534 |
| 26 | tetrahydrofolate metabolic process (GO:0046653) | 4.09890864 |
| 27 | folic acid-containing compound metabolic process (GO:0006760) | 4.06131692 |
| 28 | protein-chromophore linkage (GO:0018298) | 3.79104532 |
| 29 | purine-containing compound salvage (GO:0043101) | 3.75203285 |
| 30 | ribosome biogenesis (GO:0042254) | 3.75092469 |
| 31 | microtubule nucleation (GO:0007020) | 3.72718791 |
| 32 | protein complex biogenesis (GO:0070271) | 3.71988673 |
| 33 | proteasome assembly (GO:0043248) | 3.71193290 |
| 34 | DNA deamination (GO:0045006) | 3.70759268 |
| 35 | rRNA modification (GO:0000154) | 3.62536891 |
| 36 | nucleotide salvage (GO:0043173) | 3.62455867 |
| 37 | protein deneddylation (GO:0000338) | 3.61016390 |
| 38 | IMP metabolic process (GO:0046040) | 3.60591648 |
| 39 | tRNA modification (GO:0006400) | 3.58294894 |
| 40 | cullin deneddylation (GO:0010388) | 3.46734539 |
| 41 | galactose catabolic process (GO:0019388) | 3.44427534 |
| 42 | desmosome organization (GO:0002934) | 3.43725124 |
| 43 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.41087727 |
| 44 | GPI anchor biosynthetic process (GO:0006506) | 3.38568275 |
| 45 | pteridine-containing compound metabolic process (GO:0042558) | 3.37848611 |
| 46 | organic cation transport (GO:0015695) | 3.36125757 |
| 47 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.35136539 |
| 48 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.34952780 |
| 49 | cytidine metabolic process (GO:0046087) | 3.34113413 |
| 50 | cytidine catabolic process (GO:0006216) | 3.34113413 |
| 51 | cytidine deamination (GO:0009972) | 3.34113413 |
| 52 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.27156862 |
| 53 | rRNA methylation (GO:0031167) | 3.26850559 |
| 54 | aldehyde catabolic process (GO:0046185) | 3.24031565 |
| 55 | polyamine biosynthetic process (GO:0006596) | 3.23232514 |
| 56 | one-carbon metabolic process (GO:0006730) | 3.21208050 |
| 57 | white fat cell differentiation (GO:0050872) | 3.20859068 |
| 58 | serine family amino acid biosynthetic process (GO:0009070) | 3.19774071 |
| 59 | sulfur amino acid biosynthetic process (GO:0000097) | 3.19232314 |
| 60 | galactose metabolic process (GO:0006012) | 3.19197579 |
| 61 | inner mitochondrial membrane organization (GO:0007007) | 3.16253441 |
| 62 | response to gravity (GO:0009629) | 3.13527558 |
| 63 | L-serine metabolic process (GO:0006563) | 3.11468414 |
| 64 | negative regulation of Ras GTPase activity (GO:0034261) | 3.10009623 |
| 65 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.04875471 |
| 66 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.03123548 |
| 67 | GPI anchor metabolic process (GO:0006505) | 3.02458151 |
| 68 | cartilage morphogenesis (GO:0060536) | 3.02037135 |
| 69 | primary amino compound metabolic process (GO:1901160) | 3.00032440 |
| 70 | negative regulation of telomerase activity (GO:0051974) | 2.99381099 |
| 71 | transcription from mitochondrial promoter (GO:0006390) | 2.97872934 |
| 72 | folic acid metabolic process (GO:0046655) | 2.97306393 |
| 73 | purine nucleobase biosynthetic process (GO:0009113) | 2.91495169 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.91086278 |
| 75 | polyamine metabolic process (GO:0006595) | 2.90807753 |
| 76 | tRNA processing (GO:0008033) | 2.90656845 |
| 77 | positive regulation of hair follicle development (GO:0051798) | 2.87639779 |
| 78 | positive regulation of hair cycle (GO:0042635) | 2.87639779 |
| 79 | regulation of vitamin metabolic process (GO:0030656) | 2.85592714 |
| 80 | cochlea development (GO:0090102) | 2.81548389 |
| 81 | viral mRNA export from host cell nucleus (GO:0046784) | 2.76022408 |
| 82 | cellular component biogenesis (GO:0044085) | 2.74410302 |
| 83 | regulation of endothelial cell differentiation (GO:0045601) | 2.73360252 |
| 84 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.71521308 |
| 85 | RNA modification (GO:0009451) | 2.70363521 |
| 86 | fucose catabolic process (GO:0019317) | 2.66225446 |
| 87 | L-fucose metabolic process (GO:0042354) | 2.66225446 |
| 88 | L-fucose catabolic process (GO:0042355) | 2.66225446 |
| 89 | regulation of sequestering of triglyceride (GO:0010889) | 2.62162855 |
| 90 | peptidyl-histidine modification (GO:0018202) | 2.61595392 |
| 91 | serine family amino acid catabolic process (GO:0009071) | 2.60943162 |
| 92 | RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502) | 2.58426651 |
| 93 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.58371193 |
| 94 | placenta development (GO:0001890) | 2.55601793 |
| 95 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.54552286 |
| 96 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.54552286 |
| 97 | rRNA metabolic process (GO:0016072) | 2.53271328 |
| 98 | rRNA processing (GO:0006364) | 2.53170322 |
| 99 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.53099725 |
| 100 | ATP synthesis coupled proton transport (GO:0015986) | 2.53099725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 9.51065684 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.03207909 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.78288489 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.57980896 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.43757485 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.41606966 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 3.32244417 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.04630578 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.98530302 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.90286792 |
| 11 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.38829977 |
| 12 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.34594020 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.29884985 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.26275541 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.17936603 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.12186454 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.05054676 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.96049803 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.89931154 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.88959944 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84921194 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.84854217 |
| 23 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.72671964 |
| 24 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.71967074 |
| 25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70566645 |
| 26 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.63526366 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.61236503 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.60117446 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59634338 |
| 30 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.56700718 |
| 31 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52820442 |
| 32 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.51435401 |
| 33 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.50581543 |
| 34 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.50530276 |
| 35 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.46182748 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37318674 |
| 37 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.35453593 |
| 38 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.30736468 |
| 39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.30628131 |
| 40 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.29592446 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28783961 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.26184661 |
| 43 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.22616892 |
| 44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22072978 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21481122 |
| 46 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21130956 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.19145756 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.18910578 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16648391 |
| 50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.16414819 |
| 51 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.16338943 |
| 52 | P300_27268052_Chip-Seq_Bcells_Human | 1.15634668 |
| 53 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.13332859 |
| 54 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.13332859 |
| 55 | NCOR_22424771_ChIP-Seq_293T_Human | 1.13036013 |
| 56 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12846840 |
| 57 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.12055936 |
| 58 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11343266 |
| 59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06536634 |
| 60 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05827499 |
| 61 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.03913846 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03785616 |
| 63 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.03149274 |
| 64 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03082627 |
| 65 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02967289 |
| 66 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02283359 |
| 67 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.01652100 |
| 68 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.98699071 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 0.97286579 |
| 70 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.97197201 |
| 71 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.96666632 |
| 72 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94934171 |
| 73 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.93384381 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92009575 |
| 75 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.91672181 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91375958 |
| 77 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.91184584 |
| 78 | AR_20517297_ChIP-Seq_VCAP_Human | 0.90174522 |
| 79 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.89985040 |
| 80 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.89736807 |
| 81 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.89285144 |
| 82 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.87509466 |
| 83 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.86577495 |
| 84 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.86309208 |
| 85 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.86239179 |
| 86 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.86018615 |
| 87 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.84945208 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 0.84849726 |
| 89 | GATA3_26560356_Chip-Seq_TH1_Human | 0.84371239 |
| 90 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83673264 |
| 91 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.83079168 |
| 92 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.83053487 |
| 93 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.83047729 |
| 94 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.82673152 |
| 95 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80278153 |
| 96 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.79680665 |
| 97 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.79237934 |
| 98 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.78543976 |
| 99 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.77634895 |
| 100 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.77179764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005646_abnormal_pituitary_gland | 5.08373691 |
| 2 | MP0000013_abnormal_adipose_tissue | 3.91999260 |
| 3 | MP0008995_early_reproductive_senescence | 3.88968607 |
| 4 | MP0005670_abnormal_white_adipose | 3.63995630 |
| 5 | MP0003724_increased_susceptibility_to | 3.52869379 |
| 6 | MP0005360_urolithiasis | 3.20798676 |
| 7 | MP0002163_abnormal_gland_morphology | 2.90383519 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.76606687 |
| 9 | MP0005645_abnormal_hypothalamus_physiol | 2.73987270 |
| 10 | MP0004147_increased_porphyrin_level | 2.70190984 |
| 11 | MP0002736_abnormal_nociception_after | 2.33474989 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.22691555 |
| 13 | MP0005671_abnormal_response_to | 2.18369161 |
| 14 | MP0002938_white_spotting | 2.17988093 |
| 15 | MP0008058_abnormal_DNA_repair | 2.05622693 |
| 16 | MP0004885_abnormal_endolymph | 2.03499069 |
| 17 | MP0001661_extended_life_span | 2.00706755 |
| 18 | MP0008872_abnormal_physiological_respon | 1.99174931 |
| 19 | MP0003786_premature_aging | 1.92498041 |
| 20 | MP0003787_abnormal_imprinting | 1.92306853 |
| 21 | MP0002102_abnormal_ear_morphology | 1.79536416 |
| 22 | MP0001764_abnormal_homeostasis | 1.78842792 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.67148282 |
| 24 | MP0001968_abnormal_touch/_nociception | 1.66942788 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.62502069 |
| 26 | MP0000516_abnormal_urinary_system | 1.59739112 |
| 27 | MP0005367_renal/urinary_system_phenotyp | 1.59739112 |
| 28 | MP0000372_irregular_coat_pigmentation | 1.54565050 |
| 29 | MP0000647_abnormal_sebaceous_gland | 1.48898579 |
| 30 | MP0003878_abnormal_ear_physiology | 1.42113109 |
| 31 | MP0005377_hearing/vestibular/ear_phenot | 1.42113109 |
| 32 | MP0005332_abnormal_amino_acid | 1.41560624 |
| 33 | MP0004043_abnormal_pH_regulation | 1.40920739 |
| 34 | MP0009764_decreased_sensitivity_to | 1.38238081 |
| 35 | MP0005084_abnormal_gallbladder_morpholo | 1.37684806 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.35853426 |
| 37 | MP0006292_abnormal_olfactory_placode | 1.31510187 |
| 38 | MP0002876_abnormal_thyroid_physiology | 1.25354646 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.23706521 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.22187996 |
| 41 | MP0005379_endocrine/exocrine_gland_phen | 1.20661729 |
| 42 | MP0000631_abnormal_neuroendocrine_gland | 1.20417799 |
| 43 | MP0000003_abnormal_adipose_tissue | 1.17760157 |
| 44 | MP0003186_abnormal_redox_activity | 1.17141451 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.14605294 |
| 46 | MP0006072_abnormal_retinal_apoptosis | 1.14026237 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 1.12170049 |
| 48 | MP0004947_skin_inflammation | 1.09411379 |
| 49 | MP0001984_abnormal_olfaction | 1.06585515 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.06082888 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.02919508 |
| 52 | MP0001800_abnormal_humoral_immune | 1.02088034 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 1.01391785 |
| 54 | MP0000534_abnormal_ureter_morphology | 0.97632721 |
| 55 | MP0005085_abnormal_gallbladder_physiolo | 0.97522987 |
| 56 | MP0009643_abnormal_urine_homeostasis | 0.97494846 |
| 57 | MP0005164_abnormal_response_to | 0.96650356 |
| 58 | MP0009046_muscle_twitch | 0.94801676 |
| 59 | MP0002006_tumorigenesis | 0.93508343 |
| 60 | MP0003718_maternal_effect | 0.91366112 |
| 61 | MP0005000_abnormal_immune_tolerance | 0.88142809 |
| 62 | MP0001986_abnormal_taste_sensitivity | 0.86840720 |
| 63 | MP0003436_decreased_susceptibility_to | 0.85915637 |
| 64 | MP0005253_abnormal_eye_physiology | 0.84033165 |
| 65 | MP0001119_abnormal_female_reproductive | 0.83337231 |
| 66 | MP0001919_abnormal_reproductive_system | 0.81341605 |
| 67 | MP0003880_abnormal_central_pattern | 0.80023922 |
| 68 | MP0002733_abnormal_thermal_nociception | 0.78756707 |
| 69 | MP0002723_abnormal_immune_serum | 0.78314409 |
| 70 | MP0005389_reproductive_system_phenotype | 0.78258055 |
| 71 | MP0000750_abnormal_muscle_regeneration | 0.76771169 |
| 72 | MP0008469_abnormal_protein_level | 0.76507208 |
| 73 | MP0000613_abnormal_salivary_gland | 0.74814098 |
| 74 | MP0001905_abnormal_dopamine_level | 0.74483902 |
| 75 | MP0000383_abnormal_hair_follicle | 0.74234642 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 0.74200019 |
| 77 | MP0004133_heterotaxia | 0.74021143 |
| 78 | MP0001845_abnormal_inflammatory_respons | 0.71852139 |
| 79 | MP0009785_altered_susceptibility_to | 0.71617296 |
| 80 | MP0002452_abnormal_antigen_presenting | 0.71022062 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.70595750 |
| 82 | MP0003936_abnormal_reproductive_system | 0.70571224 |
| 83 | MP0009697_abnormal_copulation | 0.69578733 |
| 84 | MP0000747_muscle_weakness | 0.68830597 |
| 85 | MP0003646_muscle_fatigue | 0.67792682 |
| 86 | MP0002396_abnormal_hematopoietic_system | 0.67601524 |
| 87 | MP0002160_abnormal_reproductive_system | 0.67335056 |
| 88 | MP0002095_abnormal_skin_pigmentation | 0.64666481 |
| 89 | MP0000639_abnormal_adrenal_gland | 0.64175652 |
| 90 | MP0001819_abnormal_immune_cell | 0.63982871 |
| 91 | MP0002420_abnormal_adaptive_immunity | 0.63689644 |
| 92 | MP0002132_abnormal_respiratory_system | 0.63669038 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.63296514 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.63120255 |
| 95 | MP0000703_abnormal_thymus_morphology | 0.62901210 |
| 96 | MP0000627_abnormal_mammary_gland | 0.62884125 |
| 97 | MP0001756_abnormal_urination | 0.62561247 |
| 98 | MP0008873_increased_physiological_sensi | 0.62506363 |
| 99 | MP0001881_abnormal_mammary_gland | 0.62065694 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.61557313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of alanine metabolism (HP:0010916) | 7.95096384 |
| 2 | Hyperalaninemia (HP:0003348) | 7.95096384 |
| 3 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 7.95096384 |
| 4 | Constricted visual fields (HP:0001133) | 6.33329738 |
| 5 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 4.34099646 |
| 6 | Attenuation of retinal blood vessels (HP:0007843) | 4.03768052 |
| 7 | Congenital sensorineural hearing impairment (HP:0008527) | 3.90231722 |
| 8 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.74852792 |
| 9 | Spontaneous hematomas (HP:0007420) | 3.55665422 |
| 10 | Chronic otitis media (HP:0000389) | 3.40290460 |
| 11 | Abnormality of serum amino acid levels (HP:0003112) | 3.31143369 |
| 12 | Esophageal varix (HP:0002040) | 3.17823936 |
| 13 | Homocystinuria (HP:0002156) | 3.00502561 |
| 14 | Abnormality of homocysteine metabolism (HP:0010919) | 3.00502561 |
| 15 | Tetany (HP:0001281) | 2.96631665 |
| 16 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.92294032 |
| 17 | Single umbilical artery (HP:0001195) | 2.92294032 |
| 18 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.92294032 |
| 19 | Abolished electroretinogram (ERG) (HP:0000550) | 2.86253418 |
| 20 | Brittle hair (HP:0002299) | 2.83825020 |
| 21 | Pigmentary retinal degeneration (HP:0001146) | 2.81534916 |
| 22 | Hyperuricemia (HP:0002149) | 2.81472239 |
| 23 | Increased purine levels (HP:0004368) | 2.81472239 |
| 24 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.77325918 |
| 25 | Anorexia (HP:0002039) | 2.64464879 |
| 26 | Poor speech (HP:0002465) | 2.62091620 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.56328088 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.54461145 |
| 29 | Patchy hypopigmentation of hair (HP:0011365) | 2.53586498 |
| 30 | White forelock (HP:0002211) | 2.52620948 |
| 31 | Chorioretinal atrophy (HP:0000533) | 2.50517821 |
| 32 | Abnormality of purine metabolism (HP:0004352) | 2.48359018 |
| 33 | Pulmonary embolism (HP:0002204) | 2.45463330 |
| 34 | Hypoplasia of the uterus (HP:0000013) | 2.40548193 |
| 35 | Hypomagnesemia (HP:0002917) | 2.36976207 |
| 36 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.35018577 |
| 37 | Hyperglycinemia (HP:0002154) | 2.33602091 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.32991467 |
| 39 | Decreased subcutaneous fat (HP:0001002) | 2.30982212 |
| 40 | Increased serum pyruvate (HP:0003542) | 2.27845778 |
| 41 | Heterochromia iridis (HP:0001100) | 2.23888741 |
| 42 | Cortical visual impairment (HP:0100704) | 2.23507853 |
| 43 | Pendular nystagmus (HP:0012043) | 2.19455363 |
| 44 | Conjunctival telangiectasia (HP:0000524) | 2.18467148 |
| 45 | Increased serum lactate (HP:0002151) | 2.16109852 |
| 46 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.15823781 |
| 47 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.14206465 |
| 48 | Myopathic facies (HP:0002058) | 2.11763643 |
| 49 | Chronic hepatic failure (HP:0100626) | 2.09942954 |
| 50 | Abnormality of the pons (HP:0007361) | 2.08374751 |
| 51 | Oligomenorrhea (HP:0000876) | 2.06482541 |
| 52 | Abnormality of dental color (HP:0011073) | 2.05516195 |
| 53 | Lactic acidosis (HP:0003128) | 2.04700540 |
| 54 | Methylmalonic acidemia (HP:0002912) | 2.03106511 |
| 55 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.02935370 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.02270755 |
| 57 | True hermaphroditism (HP:0010459) | 1.97985901 |
| 58 | Mitochondrial inheritance (HP:0001427) | 1.97544189 |
| 59 | Potter facies (HP:0002009) | 1.95585078 |
| 60 | Facial shape deformation (HP:0011334) | 1.95585078 |
| 61 | IgG deficiency (HP:0004315) | 1.95078918 |
| 62 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.92624943 |
| 63 | Abnormality of DNA repair (HP:0003254) | 1.92507926 |
| 64 | Pancreatic fibrosis (HP:0100732) | 1.92363545 |
| 65 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.91759701 |
| 66 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.91759701 |
| 67 | Granulocytopenia (HP:0001913) | 1.91478300 |
| 68 | Abnormality of glycolysis (HP:0004366) | 1.91253575 |
| 69 | Arthropathy (HP:0003040) | 1.88781310 |
| 70 | Birth length less than 3rd percentile (HP:0003561) | 1.87663634 |
| 71 | Myocardial infarction (HP:0001658) | 1.83168411 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 1.82944545 |
| 73 | Abnormality of the renal collecting system (HP:0004742) | 1.82868440 |
| 74 | Thrombophlebitis (HP:0004418) | 1.82773910 |
| 75 | Optic disc pallor (HP:0000543) | 1.82217092 |
| 76 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.80913342 |
| 77 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.80282449 |
| 78 | Abnormality of magnesium homeostasis (HP:0004921) | 1.79512361 |
| 79 | Recurrent corneal erosions (HP:0000495) | 1.79336518 |
| 80 | Maternal diabetes (HP:0009800) | 1.79234512 |
| 81 | Hypoplastic left heart (HP:0004383) | 1.77337605 |
| 82 | Orthostatic hypotension (HP:0001278) | 1.76061669 |
| 83 | Biconcave vertebral bodies (HP:0004586) | 1.76038001 |
| 84 | Methylmalonic aciduria (HP:0012120) | 1.75284986 |
| 85 | Short tibia (HP:0005736) | 1.74395770 |
| 86 | Hyperphosphaturia (HP:0003109) | 1.73176832 |
| 87 | Hypoalphalipoproteinemia (HP:0003233) | 1.72803194 |
| 88 | Type II diabetes mellitus (HP:0005978) | 1.72269244 |
| 89 | Chronic sinusitis (HP:0011109) | 1.71094039 |
| 90 | Hypergonadotropic hypogonadism (HP:0000815) | 1.70859349 |
| 91 | Abnormality of eosinophils (HP:0001879) | 1.70081419 |
| 92 | Duplicated collecting system (HP:0000081) | 1.70042709 |
| 93 | Chronic diarrhea (HP:0002028) | 1.69956716 |
| 94 | Type II lissencephaly (HP:0007260) | 1.68515897 |
| 95 | Nausea (HP:0002018) | 1.68329522 |
| 96 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67396495 |
| 97 | Increased CSF lactate (HP:0002490) | 1.67144979 |
| 98 | Acute necrotizing encephalopathy (HP:0006965) | 1.67101966 |
| 99 | Generalized aminoaciduria (HP:0002909) | 1.66768731 |
| 100 | Pustule (HP:0200039) | 1.65148667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 6.92059373 |
| 2 | TLK1 | 6.68278182 |
| 3 | MAP4K2 | 4.25775871 |
| 4 | VRK1 | 2.56613937 |
| 5 | BCKDK | 2.46869804 |
| 6 | MAP2K3 | 2.32755999 |
| 7 | LMTK2 | 2.29241480 |
| 8 | VRK2 | 2.26826399 |
| 9 | TAOK3 | 2.17357616 |
| 10 | MAP3K3 | 2.00150838 |
| 11 | MST4 | 1.96051910 |
| 12 | TNK2 | 1.81843067 |
| 13 | RPS6KB2 | 1.75957222 |
| 14 | TSSK6 | 1.71113437 |
| 15 | NME2 | 1.64484402 |
| 16 | MAP4K1 | 1.61404506 |
| 17 | ADRBK2 | 1.43897187 |
| 18 | CDK8 | 1.33850031 |
| 19 | NTRK2 | 1.29624133 |
| 20 | MAPKAPK5 | 1.24977152 |
| 21 | JAK3 | 1.22345183 |
| 22 | CDK9 | 1.21879829 |
| 23 | NTRK1 | 1.19285885 |
| 24 | FGR | 1.11590258 |
| 25 | IKBKB | 1.06939747 |
| 26 | MAPKAPK3 | 1.06884210 |
| 27 | MKNK1 | 1.06505770 |
| 28 | CSNK1G3 | 0.94699654 |
| 29 | CSNK1G1 | 0.94360737 |
| 30 | SRPK1 | 0.94280064 |
| 31 | ADRBK1 | 0.92214385 |
| 32 | ACVR1B | 0.91265603 |
| 33 | CSNK1A1L | 0.90492632 |
| 34 | RPS6KA5 | 0.85323809 |
| 35 | SGK494 | 0.85192022 |
| 36 | SGK223 | 0.85192022 |
| 37 | ABL2 | 0.84902571 |
| 38 | EIF2AK3 | 0.84725913 |
| 39 | SCYL2 | 0.84222042 |
| 40 | PHKG2 | 0.82795805 |
| 41 | PHKG1 | 0.82795805 |
| 42 | IKBKE | 0.82614861 |
| 43 | MATK | 0.78490313 |
| 44 | SGK2 | 0.78256415 |
| 45 | TXK | 0.75625566 |
| 46 | DYRK2 | 0.75090030 |
| 47 | CSNK1A1 | 0.73006288 |
| 48 | GRK1 | 0.71412792 |
| 49 | AURKA | 0.71112310 |
| 50 | SYK | 0.69711343 |
| 51 | BUB1 | 0.68738605 |
| 52 | TIE1 | 0.68361571 |
| 53 | TNIK | 0.67528223 |
| 54 | PIM1 | 0.66403039 |
| 55 | DAPK2 | 0.65726815 |
| 56 | PRKCQ | 0.65236584 |
| 57 | NTRK3 | 0.62146206 |
| 58 | KDR | 0.61969690 |
| 59 | NEK6 | 0.61691596 |
| 60 | NUAK1 | 0.60623401 |
| 61 | TRPM7 | 0.60403660 |
| 62 | MAP2K1 | 0.58091325 |
| 63 | PKN1 | 0.56825498 |
| 64 | MAP3K14 | 0.56211438 |
| 65 | CSNK1G2 | 0.53596048 |
| 66 | GRK6 | 0.50811394 |
| 67 | OBSCN | 0.49956615 |
| 68 | MAPK13 | 0.48839052 |
| 69 | PLK3 | 0.48418442 |
| 70 | BMPR1B | 0.47335198 |
| 71 | PRKG2 | 0.47065859 |
| 72 | PRKD3 | 0.46854209 |
| 73 | CDK7 | 0.46481059 |
| 74 | PDK2 | 0.46084681 |
| 75 | GRK7 | 0.45318757 |
| 76 | AKT2 | 0.44852594 |
| 77 | EPHB2 | 0.43788910 |
| 78 | EPHA2 | 0.40256721 |
| 79 | FES | 0.39308990 |
| 80 | RIPK1 | 0.37604883 |
| 81 | ITK | 0.37484592 |
| 82 | ALK | 0.37211275 |
| 83 | EPHA3 | 0.36532138 |
| 84 | EIF2AK2 | 0.35802749 |
| 85 | INSRR | 0.35644808 |
| 86 | CSNK2A1 | 0.35641782 |
| 87 | RPS6KA4 | 0.34238395 |
| 88 | INSR | 0.33980089 |
| 89 | RPS6KB1 | 0.33504256 |
| 90 | CCNB1 | 0.33276540 |
| 91 | TRIM28 | 0.32761070 |
| 92 | SGK3 | 0.32087216 |
| 93 | GRK5 | 0.31194867 |
| 94 | PRKCA | 0.31106710 |
| 95 | ATR | 0.30410976 |
| 96 | TAF1 | 0.30383279 |
| 97 | OXSR1 | 0.30000036 |
| 98 | KIT | 0.29872767 |
| 99 | LYN | 0.27496219 |
| 100 | TEC | 0.26949866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | One carbon pool by folate_Homo sapiens_hsa00670 | 4.87123196 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.26933152 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.65520075 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 2.52948011 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.44589867 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.30081055 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.28199570 |
| 8 | Basal transcription factors_Homo sapiens_hsa03022 | 2.01166285 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.99765024 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 1.98971524 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.92815420 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 1.88517089 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.86192832 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 1.84969119 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.82110423 |
| 16 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.76010702 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.72315810 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68931358 |
| 19 | RNA degradation_Homo sapiens_hsa03018 | 1.67113365 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61445152 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.59672571 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.55260080 |
| 23 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.54071143 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.45556588 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45411247 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.44249384 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.40102589 |
| 28 | Base excision repair_Homo sapiens_hsa03410 | 1.29184716 |
| 29 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.27278713 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21442431 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.21229881 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.20540607 |
| 33 | Protein export_Homo sapiens_hsa03060 | 1.18538916 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.17032298 |
| 35 | RNA transport_Homo sapiens_hsa03013 | 1.15554818 |
| 36 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.15358305 |
| 37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.09054849 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08954758 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07965066 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07476530 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.05497685 |
| 42 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04566153 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 1.01739158 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00551468 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 1.00104756 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97340452 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 0.97295656 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96386461 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95041890 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 0.94961377 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92889368 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92555843 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91533861 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90823170 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 0.90018254 |
| 56 | Purine metabolism_Homo sapiens_hsa00230 | 0.88291636 |
| 57 | DNA replication_Homo sapiens_hsa03030 | 0.86940008 |
| 58 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85486769 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85363156 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.84643600 |
| 61 | Alcoholism_Homo sapiens_hsa05034 | 0.84543416 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81961817 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81480134 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79932375 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79229386 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78490699 |
| 67 | Mismatch repair_Homo sapiens_hsa03430 | 0.77810413 |
| 68 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77258933 |
| 69 | Nicotine addiction_Homo sapiens_hsa05033 | 0.75646097 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66163680 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65918717 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.62776661 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62017364 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60218926 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59763818 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57113586 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56958771 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55736538 |
| 79 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55070392 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53648944 |
| 81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.53093594 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51480009 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50224028 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50007593 |
| 85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49742491 |
| 86 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49167042 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.48991142 |
| 88 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.48795437 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46651430 |
| 90 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45372428 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44632823 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42429430 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41934062 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40803983 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39965972 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38462254 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38046463 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.37278809 |
| 99 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36058444 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35979384 |

